Eye Hospital, the First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Mol Biol Rep. 2021 Aug;48(8):6145-6150. doi: 10.1007/s11033-021-06596-3. Epub 2021 Jul 31.
N6-methyladenosine (m6A) is the most common form of internal RNA modification in eukaryotes. The dynamic regulation of m6A modification mainly rely on three proteases, installed by m6A methyltransferase, removed by m6A demethylase and recognized by m6A reader protein, which regulates the metabolism of RNA, thereby regulating the processes of cell proliferation, migration, invasion and apoptosis. Recently, a number of studies have found that m6A aberrant methylation in some eye diseases. This review was to summarize the recent research progress on the role of m6A modification in eye diseases and give a perspective on its prospective applications in eye diseases.
N6-甲基腺嘌呤(m6A)是真核生物中最常见的内部 RNA 修饰形式。m6A 修饰的动态调控主要依赖于三种蛋白酶,它们由 m6A 甲基转移酶安装,由 m6A 去甲基酶去除,由 m6A 读蛋白识别,从而调节 RNA 的代谢,进而调节细胞增殖、迁移、侵袭和凋亡等过程。最近,一些研究发现一些眼部疾病中 m6A 甲基化异常。本文综述了 m6A 修饰在眼部疾病中的作用的最新研究进展,并对其在眼部疾病中的应用前景进行了展望。